Health · 26 views
Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder
Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene…
Summary
Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Drug decriminalization in BC reduced police encounters for drug possession, with no changes in drug-related deathsContinue reading
- Zipalertinib plus chemotherapy significantly extends progression-free survival in first-line EGFR lung cancerContinue reading
- Aging oxidation drives brain proteins into harmful condensates, study findsContinue reading
- New analysis points to low overdiagnosis in breast cancer screeningContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow